This new partnership will provide integrated end-to-end solutions from sample to report for whole genome nanopore sequencing in future clinical applications.

Press Releases Partnerships News

Oxford Nanopore Technologies and Saphetor announce a new partnership to deliver tertiary analysis for comprehensive interpretation of nanopore sequencing

By Carl Smith on October 25, 2023

0

Lausanne, Switzerland, October 17,2023 – Saphetor SA today announces that it is partnering with world-leading healthcare intelligence and clinical research organization ICON to develop an innovative approach to support the planning and execution of...

Press Releases Partnerships News

Saphetor partners with ICON to develop innovative data-centric approach to precision medicine clinical trial strategies to help support unique patients

By Carl Smith on October 17, 2023

0

Saphetor are taking part in the Genomics Unlocked Webinar Series, as part of a partnership with MGI Europe. The webinar, Clinical Exomes: Sequencing to Reporting, demonstrates the full clinical exome workflow from sample to report generation...

Partnerships Events News

Webinar: Clinical Exomes to Reporting

By Carl Smith on May 30, 2023

1

Abu Dhabi, October 24, 2022: In a step aimed at boosting its clinical genomics capabilities in the region and beyond, G42 Healthcare, Abu Dhabi-based leading AI health-tech company, has announced a partnership with Saphetor SA, a Swiss precision...

Press Releases Partnerships News

G42 Healthcare strengthens clinical genomics offering with Saphetor’s VarSome bioinformatics platform, strengthens UAE’s position as a global leader in healthcare innovation

By Carl Smith on October 24, 2022

0

VarSome is exhibiting at this year's ASHG annual meeting in Los Angeles.

Conferences Partnerships Events News

VarSome at ASHG 2022

By Carl Smith on October 20, 2022

0

RIYADH, Kingdom of Saudi Arabia--(BUSINESS WIRE)--King Faisal Specialist Hospital and Research Centre (KFSH&RC) will integrate Saphetor’s proprietary human genome variant interpretation engine, VarSome, into its research and clinical genomics...

Press Releases Partnerships News

King Faisal Specialist Hospital & Research Centre to Power Genomic Interpretation with VarSome

By Carl Smith on September 28, 2022

0

Lausanne, Switzerland - September 15, 2022 - Saphetor SA, a Switzerland-based precision medicine company recognized for its industry leading variant interpretation platform VarSome, has been successfully selected as one of the twelve companies to...

Press Releases Partnerships News

Instand-NGS4P tender selects Saphetor's VarSome

By Carl Smith on September 15, 2022

0

Partnerships VarSome Clinical News

Gencell Pharma S.A.S. to adopt VarSome Clinical for high-throughput analysis of clinical exomes and genomes sequenced on MGI DNBSEQ-G400 and T7 platforms

By Carl Smith on March 29, 2022

0

Lausanne, Switzerland - March 11, 2021 - Saphetor SA, a Swiss-based precision medicine company specializing in analysis and interpretation of genomic data, announced today a distribution agreement with BioCat GmbH, a leading provider of innovative...

Partnerships

BioCat to distribute VarSome Clinical in Germany & Austria

By Tomas Kucera on March 11, 2021

1

Lausanne, Switzerland - February 25, 2021 - Saphetor SA, a Switzerland-based precision medicine company using bioinformatics to apply human genome data to benefit people, announced today a distribution agreement with Annar Health Technologies...

Partnerships

AnnarDX to distribute VarSome Clinical in Colombia

By Tomas Kucera on February 25, 2021

0

Lausanne, Switzerland - July 22, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with ELTA 90...

Partnerships

Elta90 to distribute VarSome Clinical in Serbia, Montenegro, Bosnia & Herzegovina

By Anna Del Llano on July 22, 2020

0

Lausanne, Switzerland - July 10, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Decode...

Partnerships

Decode Science to distribute VarSome Clinical in Australia and New Zealand

By Tomas Kucera on July 10, 2020

0